Understanding Different Stakeholders' Priorities for an Independent Panel on Evidence for Action on AMR

Antimicrobial resistance (AMR) is a growing global threat that demands coordinated, cross-sectoral action rooted in rigorous evidence and inclusive governance. In response to calls for an Independent Panel on Evidence for Action against AMR, this working paper presents insights from a global consultation process involving 60 experts and stakeholders across human, animal, and environmental health, policy, academia, civil society, and industry. The findings highlight key considerations for the panel’s formation, including the need for equitable representation, scientific and political legitimacy, sustained funding, and practical mechanisms to ensure evidence translation into action. Stakeholders advocate for a hybrid governance model, strategic partnerships rather than structural dependencies, and transparent, participatory processes. According to stakeholders, the panel must be context-sensitive, responsive to low- and middle-income country priorities, and capable of guiding both global coherence and locally meaningful implementation. This paper offers a roadmap for designing an independent panel that can credibly and effectively support the global response to AMR.